Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer-Reference-Cited by-同舟云学术

Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer

Published:2016-10 Issue: Volume:61 Page:159-165
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Lei Yu,Xie Yuying,Tan Yee Sun,Prince Mark E.,Moyer Jeffrey S.,Nör Jacques,Wolf Gregory T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference100 articles.

1. Tumor infiltrating lymphocytes;Klein;Ann New York Acad Sci.,1976

2. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis;Wolf;Otolaryngol–Head Neck Surgery: Official J Am Acad Otolaryngol-Head Neck Surgery,1986

3. An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes;Boheim;Arch Otorhinolaryngol,1987

4. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck;Whiteside;Cancer Res,1993

5. Perilymphatic injections of recombinant interleukin-2 (rIL-2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma;Melioli;Laryngoscope,1992

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types;Cancers;2024-04-23

3. BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation;BMC Medical Genomics;2024-02-01

4. Lymphocyte-to-Monocyte Ratio Might Serve as a Prognostic Marker in Young Patients with Tongue Squamous Cell Carcinoma;Journal of Personalized Medicine;2024-01-30

5. Developing and validating the model of tumor-infiltrating immune cell to predict survival in patients receiving radiation therapy for head and neck squamous cell carcinoma;Translational Cancer Research;2024-01